Edition:
United Kingdom

People: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

453.30INR
11:20am BST
Change (% chg)

Rs7.60 (+1.71%)
Prev Close
Rs445.70
Open
Rs443.50
Day's High
Rs456.30
Day's Low
Rs443.00
Volume
968,731
Avg. Vol
891,311
52-wk High
Rs711.90
52-wk Low
Rs423.65

Sarwate, Milind 

Shri. Milind Shripad Sarwate serves as Non-Executive Independent Director of the Company. Mr. Sarwate is the Founder and CEO of Increate Value Advisors LLP, a firm that facilitates organisations and individuals to discover, develop and deliver business and social value. He has over 32 years of experience in Finance, HR and Strategy in groups such as Marico and Godrej.

Basic Compensation

Total Annual Compensation, INR 1,600,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 1,600,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Saldanha

161,620,000

V. S. Mani

21,140,000

Harish Kuber

2,750,000

Cherylann Pinto

42,940,000

Rajesh Desai

1,200,000

Blanche Saldanha

400,000
As Of  31 Mar 2018